New point-of-care test for COVID-19 could assess need for booster Developed by Australian scientists, experts say the test could be the key to staying one step ahead of COVID-19 variants.
Cheaper treatments for cancer, Parkinson’s and motor neurone patients Changes to the Pharmaceutical Benefits Scheme will see some patients saving up to $300,000 per year.